Q&A with Vadim Alexandre Head of Research at Northland Capital Partners
26th January 2017
Northland Capital Partners’ Vadim Alexandre discusses ImmuPharma PLC in this exclusive interview with DirectorsTalk
Northland Capital Partners’ Vadim Alexandre discusses ImmuPharma PLC in this exclusive interview with DirectorsTalk
This month’s feature article is the first publication of the top 15 drug companies in the 2015 global industry ranking and how this has changed over the last decade. In
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
